Nicolas Cuniere

2 Patents

• US123782462025

  Synthetic Options Towards the Manufacture of (6r,10s)-10-{4-[5-chloro-2-(4-chloro-1h-1,2,3-triazol-1-yl)phenyl]-6-oxo-1(6h)-pyrimidinyl} - 1-(difluoromethyl)-6-methyl-1,4,7,8,9,10-hexahydro-11,15-(metheno)pyrazolo[4,3-b][1,7]diazacyclotetradecin-5(6h)-one

  Janssen Pharmaceutica NV

  0 cites
• US121292642024

  Crystalline Forms of a PAR4 Inhibitor

  Bristol-myers Squibb Company

  0 cites